|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,900 KRW | -1.67% |
|
-9.92% | -3.28% |
ImmPACT Bio USA Inc. announced that it will issue 1,478,864 series A preferred shares at issue price of $13.5239 per share for the gross proceeds $20,000,008.8496 in funding on June 9, 2020. The shares are convertible and cumulative. The shares carry cumulative fixed dividend rate of 8% per annum.
The shares will be convertible in common shares at a fixed conversion price of $13.5239 per share.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.28% | 296M | |
| +18.04% | 42.95B | |
| +16.92% | 21.38B | |
| +18.33% | 15.05B | |
| +19.27% | 14.45B | |
| +56.12% | 13.04B | |
| -0.05% | 6.79B | |
| -10.73% | 6.72B | |
| -8.87% | 5.73B | |
| +11.21% | 5.47B |
BUKWANG PHARMACEUTICAL CO., LTD. 
